DL-Aminoglutethimide
≥98%
- Product Code: 74060
CAS:
125-84-8
| Molecular Weight: | 232.28 g./mol | Molecular Formula: | C₁₃H₁₆N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 152-154 °C | Boiling Point: | 457.4ºC |
| Density: | 1.173 g/cm3 | Storage Condition: | room temperature, dry |
Product Description:
DL-Aminoglutethimide is primarily used in the medical field for its ability to inhibit steroidogenesis, making it valuable in the treatment of certain hormone-dependent conditions. It is commonly employed in the management of Cushing's syndrome, a disorder caused by excessive cortisol production. By blocking the conversion of cholesterol to pregnenolone, it reduces the synthesis of cortisol, alleviating symptoms associated with the syndrome.
Additionally, it has been utilized in the treatment of advanced breast cancer, particularly in postmenopausal women. Its mechanism involves suppressing the production of estrogen, which can fuel the growth of hormone-sensitive tumors. This makes it a useful adjunct in hormone therapy for cancer patients.
In veterinary medicine, DL-Aminoglutethimide has also been explored for its potential to treat adrenal gland disorders in animals, particularly in cases of hyperadrenocorticism (Cushing's disease). Its ability to modulate steroid production makes it a versatile tool in both human and animal healthcare.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White crystalline powder |
| PURITY | 98-100 |
| MELTING POINT | 150-153 |
| LOSS ON DRYING | 0.5 |
| PROTON NMR SPECTRUM | CONFORMS TO STRUCTURE |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | €25.85 |
+
-
|
| 5.000 | 10-20 days | €77.56 |
+
-
|
| 25.000 | 10-20 days | €277.01 |
+
-
|
DL-Aminoglutethimide
DL-Aminoglutethimide is primarily used in the medical field for its ability to inhibit steroidogenesis, making it valuable in the treatment of certain hormone-dependent conditions. It is commonly employed in the management of Cushing's syndrome, a disorder caused by excessive cortisol production. By blocking the conversion of cholesterol to pregnenolone, it reduces the synthesis of cortisol, alleviating symptoms associated with the syndrome.
Additionally, it has been utilized in the treatment of advanced breast cancer, particularly in postmenopausal women. Its mechanism involves suppressing the production of estrogen, which can fuel the growth of hormone-sensitive tumors. This makes it a useful adjunct in hormone therapy for cancer patients.
In veterinary medicine, DL-Aminoglutethimide has also been explored for its potential to treat adrenal gland disorders in animals, particularly in cases of hyperadrenocorticism (Cushing's disease). Its ability to modulate steroid production makes it a versatile tool in both human and animal healthcare.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :